IZERVAY (avacincaptad pegol intravitreal solution)

IZERVAY is a prescription medicine used to treat geographic atrophy (GA). FDA approved avacincaptad pegol (brand name IZERVAY) is not (yet) registered or available in India but on request Indian patient can buy IZERVAY at the lowest price.

IZERVAY-avacincaptad pegol-Price-Delhi-India
IZERVAY (avacincaptad pegol intravitreal solution)

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

IZERVAY (avacincaptad pegol intravitreal solution)

Tezacaftor/ivacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 6 years of age and older. It is only used for patients who have two copies of F508del mutation, or who have at least one mutation in their CF transmembrane conductance regulator (CFTR) gene.

IZERVAY is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD)

Avacincaptad pegol is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.

IZERVAY (avacincaptad pegol intravitreal solution) Initial U.S. Approval: 2023
—————-
Current Indication: Treat of geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
—————-
Marketed By: IVERIC bio, Inc.
—————-
Approval Date: : 2023
—————-

Intravitreal solution: 20 mg/mL in a single-dose vial

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.